Actinium Pharmaceuticals
ATNM
ATNM
43 hedge funds and large institutions have $4.24M invested in Actinium Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Holders
43
Holding in Top 10
–
Calls
$78K
Puts
–
Top Buyers
| 1 | +$587K | |
| 2 | +$39K | |
| 3 | +$34.4K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$27.8K |
| 5 |
Renaissance Technologies
New York
|
+$27.6K |
Top Sellers
| 1 | -$566K | |
| 2 | -$63K | |
| 3 | -$36K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$26K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$22K |